ArticleBritish journal of cancer2013
Characteristics and screening history of women diagnosed with cervical cancer aged 20-29 years.
Article in British journal of cancer, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed.
- A comparative analysis of somatic mutational profiles according to HIV status among women with cervical intraepithelial neoplasia 3 (CIN3): a focus on hotspots in TP53, PIK3CA, PTEN, and EGFR.Infectious agents and cancer · 2025Article
- Association between HPV vaccination and cervical screening policy changes and cervical cancer incidence and grade-3 cervical intraepithelial neoplasia incidence in England, 2006-2020: a population-based trends analysis.The Lancet regional health. Europe · 2025Article
- Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer.Frontiers in medicine · 2024Article
- Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.Obstetrics & gynecology science · 2023Article
- Age-Specific Trends of Invasive Cervical Cancer Incidence in British Columbia, Canada, 1971-2017.Current oncology (Toronto, Ont.) · 2023Article
- Cervical Cancer Screening with HPV Testing: Updates on the Recommendation.Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2022Article
- Interobserver agreement of transvaginal ultrasound and magnetic resonance imaging in local staging of cervical cancer.Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology · 2021Article
- Impact of changes to cervical screening guidelines on age and interval at which women are tested: Population-based study.Journal of medical screening · 2021Article
- Cervical cancer in women under 30 years of age in Norway: a population-based cohort study.BMC women's health · 2021Article
- Prevalence of Human Papillomavirus and Genotype Distribution in Pregnant and Non-Pregnant Women in China.Risk management and healthcare policy · 2021Article
- Trends in Cervical Cancer Mortality in Brazilian Women who are Screened and Not Screened.Asian Pacific journal of cancer prevention : APJCP · 2020Article
- Stage and histology of cervical cancer in women under 25 years old.Journal of gynecologic oncology · 2019Article
- Article
- Article
- Is the recent increase in cervical cancer in women aged 20-24years in England a cause for concern?Preventive medicine · 2018Article
- Early Age at First Sexual Intercourse is Associated with Higher Prevalence of High-grade Squamous Intraepithelial Lesions (HSIL).Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia · 2017Observational
- Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case-control study.British journal of cancer · 2016Article
- Evaluating cytology for the detection of invasive cervical cancer.Cytopathology : official journal of the British Society for Clinical Cytology · 2016Article
- Poor Cervical Cancer Screening Attendance and False Negatives. A Call for Organized Screening.PloS one · 2016Article
- Underscreened Women Remain Overrepresented in the Pool of Cervical Cancer Cases in Spain: A Need to Rethink the Screening Interventions.BioMed research international · 2015Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
5 authors.
Funding
Abstract
backgroundThere was concern that failure to screen women aged 20-24 years would increase the number of cancers or advanced cancers in women aged 20-29 years. We describe the characteristics of women diagnosed with cervical cancer in England aged 20-29 years and examine the association between the period of diagnosis, screening history and FIGO stage.
methodsWe used data on 1800 women diagnosed with cervical cancer between April 2007 and March 2012 at age 20-29 from the National Audit of Invasive Cervical Cancers.
resultsThe majority of cancers (995, or 62% of those with known stage) were stage 1A. Cancer at age 20-24 years was rare (12% of those aged 20-29 years), when compared with age 25 (24%) and age 26-29 years (63%); however, cancers in women aged 20-24 years tended to be more advanced and were more often of a rare histological type. For 59% of women under age 30, the cervical cancer was screen detected, most of them (61%) as a result of their first screening test. A three-fold increase in the number of cancers diagnosed at age 25 years was seen since the start of the study period.
conclusionCervical cancer at age 20-24 years is rare. Most cancers in women under age 30 years are screen detected as microinvasive cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.